Carregant...
Abaloparatide at the same dose has the same effects on bone as PTH (1-34) in mice
Abaloparatide, a novel analog of parathyroid hormone-related protein (PTHrP 1-34) became, in 2017, the second osteoanabolic therapy for the treatment of osteoporosis. This study aims to compare the effects of PTH (1-34), PTHrP (1-36), and abaloparatide on bone remodeling in male mice. Intermittent d...
Guardat en:
| Publicat a: | J Bone Miner Res |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7145759/ https://ncbi.nlm.nih.gov/pubmed/31793033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.3930 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|